Dr. Byron Lee Limmer, MD

Dr. Limmer practices at Sagis Diagnostics - Houston (Directors Row) in Houston, Texas.

Dr. Limmer's NPI, 1407963796, was assigned on August 24, 2006. Dr. Limmer graduated from UT Southwestern Medical Center in 1989. Dr. Limmer holds Texas license H8212.

Dr. Limmer's primary practice is Sagis Diagnostics - Houston (Directors Row), at 4131 Directors Row, Houston, TX 77092. The practice phone is (877) 697-2447.

Dr. Limmer's primary practice is Sagis Diagnostics - Houston (Directors Row) in Houston, Texas. The medical group on file is Limmer Dermatology. Dmand AI also links Dr. Limmer to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Limmer practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Limmer's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Limmer is board certified in dermatology by the American Board of Dermatology. Dr. Limmer is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Limmer treats.

CMS data shows 6,986 Medicare services from Dr. Limmer across 27 procedure codes in 2024, for 949 Medicare patients. Medicare paid $413,527 for them. Every service was in an office.

CMS counts 949 Medicare patients who saw Dr. Limmer in 2024. The largest group is 75 to 84, with 456 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Limmer's median patient age at 76, with 35% women.

In 2024, Dr. Limmer wrote 543 Medicare Part D claims for 254 patients. 92% of them were for generic drugs. CMS names the drug for 394 of them, across 14 drugs with 11 or more claims each, at $62,200 in total drug cost. In 2023, CMS named 304 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Limmer for performance year 2024, reported as part of a group. Dr. Limmer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,659 procedures of removal of skin lesions by Dr. Limmer, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Limmer in 2022. The most frequent topics are Skin Neoplasms. Dr. Limmer's most frequent co-authors are Eva Hudgins Kerby, MD, Shelby R. Lies, MD and Rachel Lynn Limmer, MD.

CMS Open Payments shows 66 general payments to Dr. Limmer from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $648.

Dmand AI lists 5 awards for Dr. Limmer, most recently Best Doctors in America, 4th Edition in 1999.

Dr. Limmer graduated from UT Southwestern Medical Center in 1989. Dr. Limmer is a member of AAD and ASDS.

Dr. Limmer is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.